125 related articles for article (PubMed ID: 22475625)
1. α-Synuclein BAC transgenic mice as a model for Parkinson's disease manifested decreased anxiety-like behavior and hyperlocomotion.
Yamakado H; Moriwaki Y; Yamasaki N; Miyakawa T; Kurisu J; Uemura K; Inoue H; Takahashi M; Takahashi R
Neurosci Res; 2012 Jun; 73(2):173-7. PubMed ID: 22475625
[TBL] [Abstract][Full Text] [Related]
2. Rapid Induction of Dopaminergic Neuron Loss Accompanied by Lewy Body-Like Inclusions in A53T BAC-SNCA Transgenic Mice.
Okuda S; Uemura N; Sawamura M; Taguchi T; Ikuno M; Uemura MT; Yamakado H; Takahashi R
Neurotherapeutics; 2022 Jan; 19(1):289-304. PubMed ID: 34935120
[TBL] [Abstract][Full Text] [Related]
3. Dopamine receptor agonists reverse behavioral abnormalities of alpha-synuclein transgenic mouse, a new model of Parkinson's disease.
Wakamatsu M; Iwata S; Funakoshi T; Yoshimoto M
J Neurosci Res; 2008 Feb; 86(3):640-6. PubMed ID: 17896793
[TBL] [Abstract][Full Text] [Related]
4. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
[TBL] [Abstract][Full Text] [Related]
5. Alpha-synuclein transgenic mice exhibit reduced anxiety-like behaviour.
George S; van den Buuse M; San Mok S; Masters CL; Li QX; Culvenor JG
Exp Neurol; 2008 Apr; 210(2):788-92. PubMed ID: 18295208
[TBL] [Abstract][Full Text] [Related]
6. Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice.
Richfield EK; Thiruchelvam MJ; Cory-Slechta DA; Wuertzer C; Gainetdinov RR; Caron MG; Di Monte DA; Federoff HJ
Exp Neurol; 2002 May; 175(1):35-48. PubMed ID: 12009758
[TBL] [Abstract][Full Text] [Related]
7. Generation of a alpha-synuclein-based rat model of Parkinson's disease.
Recchia A; Rota D; Debetto P; Peroni D; Guidolin D; Negro A; Skaper SD; Giusti P
Neurobiol Dis; 2008 Apr; 30(1):8-18. PubMed ID: 18313315
[TBL] [Abstract][Full Text] [Related]
8. A novel α-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of α-synuclein-GFP.
Hansen C; Björklund T; Petit GH; Lundblad M; Murmu RP; Brundin P; Li JY
Neurobiol Dis; 2013 Aug; 56():145-55. PubMed ID: 23643841
[TBL] [Abstract][Full Text] [Related]
9. G protein-coupled receptor kinase 5, overexpressed in the alpha-synuclein up-regulation model of Parkinson's disease, regulates bcl-2 expression.
Liu P; Wang X; Gao N; Zhu H; Dai X; Xu Y; Ma C; Huang L; Liu Y; Qin C
Brain Res; 2010 Jan; 1307():134-41. PubMed ID: 19852948
[TBL] [Abstract][Full Text] [Related]
10. Beyond α-synuclein transfer: pathology propagation in Parkinson's disease.
Hansen C; Li JY
Trends Mol Med; 2012 May; 18(5):248-55. PubMed ID: 22503115
[TBL] [Abstract][Full Text] [Related]
11. Wild-type and mutant alpha-synuclein induce a multi-component gene expression profile consistent with shared pathophysiology in different transgenic mouse models of PD.
Miller RM; Kiser GL; Kaysser-Kranich T; Casaceli C; Colla E; Lee MK; Palaniappan C; Federoff HJ
Exp Neurol; 2007 Mar; 204(1):421-32. PubMed ID: 17254569
[TBL] [Abstract][Full Text] [Related]
12. Olfactory neuron-specific expression of A30P α-synuclein exacerbates dopamine deficiency and hyperactivity in a novel conditional model of early Parkinson's disease stages.
Nuber S; Petrasch-Parwez E; Arias-Carrión O; Koch L; Kohl Z; Schneider J; Calaminus C; Dermietzel R; Samarina A; Boy J; Nguyen HP; Teismann P; Velavan TP; Kahle PJ; von Hörsten S; Fendt M; Krüger R; Riess O
Neurobiol Dis; 2011 Nov; 44(2):192-204. PubMed ID: 21767644
[TBL] [Abstract][Full Text] [Related]
13. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
[TBL] [Abstract][Full Text] [Related]
14. Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease.
Masliah E; Rockenstein E; Adame A; Alford M; Crews L; Hashimoto M; Seubert P; Lee M; Goldstein J; Chilcote T; Games D; Schenk D
Neuron; 2005 Jun; 46(6):857-68. PubMed ID: 15953415
[TBL] [Abstract][Full Text] [Related]
15. Brain infusion of α-synuclein oligomers induces motor and non-motor Parkinson's disease-like symptoms in mice.
Fortuna JTS; Gralle M; Beckman D; Neves FS; Diniz LP; Frost PS; Barros-Aragão F; Santos LE; Gonçalves RA; Romão L; Zamberlan DC; Soares FAA; Braga C; Foguel D; Gomes FCA; De Felice FG; Ferreira ST; Clarke JR; Figueiredo CP
Behav Brain Res; 2017 Aug; 333():150-160. PubMed ID: 28668282
[TBL] [Abstract][Full Text] [Related]
16. Early Parkinson's disease symptoms in α-synuclein transgenic monkeys.
Niu Y; Guo X; Chen Y; Wang CE; Gao J; Yang W; Kang Y; Si W; Wang H; Yang SH; Li S; Ji W; Li XJ
Hum Mol Genet; 2015 Apr; 24(8):2308-17. PubMed ID: 25552648
[TBL] [Abstract][Full Text] [Related]
17. Chronic exposure to manganese decreases striatal dopamine turnover in human alpha-synuclein transgenic mice.
Peneder TM; Scholze P; Berger ML; Reither H; Heinze G; Bertl J; Bauer J; Richfield EK; Hornykiewicz O; Pifl C
Neuroscience; 2011 Apr; 180():280-92. PubMed ID: 21333719
[TBL] [Abstract][Full Text] [Related]
18. Age-Dependent Alpha-Synuclein Accumulation and Phosphorylation in the Enteric Nervous System in a Transgenic Mouse Model of Parkinson's Disease.
Zhong CB; Chen QQ; Haikal C; Li W; Svanbergsson A; Diepenbroek M; Li JY
Neurosci Bull; 2017 Oct; 33(5):483-492. PubMed ID: 28924920
[TBL] [Abstract][Full Text] [Related]
19. Proteasome dysfunction in aged human alpha-synuclein transgenic mice.
Chen L; Thiruchelvam MJ; Madura K; Richfield EK
Neurobiol Dis; 2006 Jul; 23(1):120-6. PubMed ID: 16713278
[TBL] [Abstract][Full Text] [Related]
20. α-Synuclein in the olfactory system of a mouse model of Parkinson's disease: correlation with olfactory projections.
Ubeda-Bañon I; Saiz-Sanchez D; de la Rosa-Prieto C; Martinez-Marcos A
Brain Struct Funct; 2012 Apr; 217(2):447-58. PubMed ID: 21928152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]